Circulating microRNAs are elevated in plasma from severe preeclamptic pregnancies

Area of Science:

• Obstetrics and Gynecology
• Molecular Biology
• Biomarker Discovery

Background:

• The molecular mechanisms underlying preeclampsia (PE) are not fully understood.
• Circulating microRNAs (miRNAs) are emerging as significant biomarkers for various physiological and pathological conditions.
• Identifying specific biomarkers for preeclampsia is crucial for early diagnosis and management.

Purpose of the Study:

• To identify differentially expressed miRNAs in plasma from pregnancies complicated by severe preeclampsia (sPE) compared to normal pregnancies.
• To investigate the potential role of these miRNAs in the pathogenesis of sPE.
• To explore the utility of these miRNAs as potential diagnostic markers for sPE.

Main Methods:

• Plasma samples were collected from women with sPE and normal pregnancies.
• Mature miRNA microarray analysis was performed to screen for differentially expressed miRNAs.
• Real-time quantitative stem-loop RT-PCR was used to validate the expression levels of selected miRNAs.
• Gene ontology and pathway enrichment analyses were conducted to understand the biological functions of identified miRNAs.

Main Results:

• Microarray analysis identified 15 differentially expressed miRNAs (13 upregulated, 2 downregulated) in sPE plasma.
• Seven miRNAs (miR-24, miR-26a, miR-103, miR-130b, miR-181a, miR-342-3p, miR-574-5p) were validated as significantly elevated in sPE plasma.
• Enrichment analyses indicated these miRNAs are involved in metabolic processes, transcription regulation, cell cycle, and signaling pathways like MAPK and TGF-β.

Conclusions:

• This study establishes the first differential expression profile of circulating miRNAs in sPE patients.
• The seven identified elevated circulating miRNAs are implicated in the pathogenesis of sPE.
• These miRNAs represent potential novel biomarkers for the diagnosis of severe preeclampsia.